APA (7th ed.) Citation

Oudot, A., Behr-Roussel, D., Poirier, S., Sandner, P., Bernabé, J., & Giuliano, F. (2011). 1075 EXPERIMENTAL EVIDENCE THAT A COMBINATION OF SGC STIMULATOR BAY 60-4552 AND PDE5 INHIBITOR VARDENAFIL MIGHT SALVAGE PATIENTS WITH INSUFFICIENT RESPONSE TO PDE5 INHIBITORS AFTER CAVERNOUS NERVE INJURY. European Urology Supplements, 10(2), 331. https://doi.org/10.1016/S1569-9056(11)61054-3

Chicago Style (17th ed.) Citation

Oudot, A., D. Behr-Roussel, S. Poirier, P. Sandner, J. Bernabé, and F. Giuliano. "1075 EXPERIMENTAL EVIDENCE THAT A COMBINATION OF SGC STIMULATOR BAY 60-4552 AND PDE5 INHIBITOR VARDENAFIL MIGHT SALVAGE PATIENTS WITH INSUFFICIENT RESPONSE TO PDE5 INHIBITORS AFTER CAVERNOUS NERVE INJURY." European Urology Supplements 10, no. 2 (2011): 331. https://doi.org/10.1016/S1569-9056(11)61054-3.

MLA (9th ed.) Citation

Oudot, A., et al. "1075 EXPERIMENTAL EVIDENCE THAT A COMBINATION OF SGC STIMULATOR BAY 60-4552 AND PDE5 INHIBITOR VARDENAFIL MIGHT SALVAGE PATIENTS WITH INSUFFICIENT RESPONSE TO PDE5 INHIBITORS AFTER CAVERNOUS NERVE INJURY." European Urology Supplements, vol. 10, no. 2, 2011, p. 331, https://doi.org/10.1016/S1569-9056(11)61054-3.